Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)
04 Mars 2019 - 11:30PM
Edgar (US Regulatory)
Filed by Edge Therapeutics, Inc.
pursuant to Rule 425 under the Securities Act of 1933
and deemed filed under Rule 14a-6(b) of the Securities Exchange Act of 1934
Subject Company: Edge Therapeutics, Inc.
Commission File No. 001-37568
EDGE THERAPEUTICS, INC. (NASDAQ:EDGE)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
EDGE THERAPEUTICS, INC. (NASDAQ:EDGE)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Edge Therapeutics, Inc. (NASDAQ): 0 recent articles
Plus d'articles sur Edge Therapeutics, Inc.